ABC News dominated the 47th annual News Emmys, taking home eight wins, including the prestigious award for outstanding live news program for “ABC World News Tonight With David Muir.” However, a strong contender emerged in the form of Nat Geo, which won seven News Emmys for its show “Trafficked With Mariana van Zeller.”
“Trafficked” was the star of the night, winning all seven awards in the series category. The show covered gripping topics such as “Brides for Sale,” “Black Market Love,” “Scam City,” “Shark Hunters,” “Underground Street Racing,” and “The Tranq Dope Underground.” Despite its successful run, the show has now come to an end, making its wins bittersweet.
The News & Documentary Emmys were split into two nights, with comedian and CNN’s “Have I Got News For You” host Amber Ruffin hosting the news categories on Wednesday, May 27. Her colleague, Michael Ian Black, was set to host the documentary categories on Thursday, May 28, marking the second night of the three-evening event at Jazz at Lincoln Center’s Frederick P. Rose Hall in New York. Roy Wood Jr., another “Have I Got News For You” star, hosted the Sports Emmys on Tuesday.
This year’s News & Documentary Emmys received over 2000 submissions, with eligible programs premiering in 2025. The nominees were selected by more than 900 peer professionals in the industry.
One of the highlights of the evening was student journalist Santiago Campos from Washington, D.C.’s District of Columbia International School. Campos impressed the News Emmys crowd by addressing changes at CBS News as he accepted the Mike Wallace Memorial Scholarship, named after the legendary CBS journalist.
The list of nominees and winners for this year’s News Emmys included several standout programs. “ABC World News Tonight with David Muir” took home the award for Outstanding Live News Program, while “The Whole Story with Anderson Cooper” won for Outstanding Recorded News Program. Other categories recognized outstanding coverage of breaking news, extended coverage, live news specials, recorded news specials, and light features in both short and long forms.
Overall, ABC News and Nat Geo emerged as the big winners of the night, showcasing the excellence and diversity of storytelling in the news industry. Fauci: The Fight for Facts (ABC News Live)
WINNER: How We Got to the Vaccines — 60 Minutes (CBS News)
The Last Days of Aaron Hernandez — 20/20 (ABC News)
The Vaccination Stories Project (PBS NewsHour Weekend)
When COVID Hit Home (Frontline | PBS)
Outstanding Business & Economic Coverage
China’s Hottest Export: Propaganda (NBC News)
Inside the World of NFTs — The Circuit with Emily Chang (Bloomberg Originals)
WINNER: The Price We Pay — 60 Minutes (CBS News)
The Real Cost of Fast Fashion — The Whole Story with Anderson Cooper (CNN Worldwide)
The Sackler Family — 60 Minutes (CBS News)
We Asked 100 People: What Is the Gig Economy? (More Perfect Union)
Outstanding International Reporting
China’s Ethnic Cleansing Campaign (NBC News)
Inside China’s Digital Gulag (NBC News)
WINNER: Inside Putin’s Russia (Frontline | PBS)
Life Under Kim Jong Un (CBS News)
Return to Fukushima — The Whole Story with Anderson Cooper (CNN Worldwide)
War in Ukraine: The Frontlines — ABC News (ABC News)
Outstanding Feature Story
Behind the Bombing: The Story of the London Blitz — 60 Minutes (CBS News)
WINNER: The Bridge: A Tale of Two Lives (CNN Worldwide)
Inside a Neo-Nazi Group (NBC News)
The Man Who Sold the World (The New York Times)
The Notorious Mr. Biden — 60 Minutes (CBS News)
The Reluctant Radical — Frontline (PBS)
Outstanding Sports Coverage
Concussion Confessions — 60 Minutes (CBS News)
Inside the MLB Lockout — MLB Network (MLB Network)
WINNER: The Making of a Legend: Inside the NFL’s Next Generation (CBS News)
The NBA’s Return: A New Era — NBA TV (NBA TV)
The Ugly Truth: The NFL and Domestic Violence (CBS News)
Young and Gay in the NFL (The New York Times)
Hello, Dynamic Pricing — The New Economy (CNN Business)
Inside the World of Luxury Real Estate — The Business of Real Estate (ABC News Studios)
WINNER: The Truth About MLMs — The Con (CBC Podcasts)
Why Is Healthcare So Expensive in America? — The Bottom Line (CNBC)
Outstanding Investigative Journalism
Black Market Gold: The Illegal Trade Behind Your Jewelry — Fault Lines (Al Jazeera International USA)
Broken Dreams: The Reality of Student Loan Debt — Impact x Nightline (ABC News Studios | Hulu)
Deadly Pollution: The Environmental Crisis in Our Backyard — View From Above (Business Insider)
WINNER: Inside the Opioid Crisis — Trafficked with Mariana van Zeller (Muck Media [National Geographic])
The Truth About Fast Fashion — The Business of Fashion (CNN Business)
Outstanding Public Service Journalism
Ending the Stigma: Mental Health Awareness in the Workplace — The Whole Story with Anderson Cooper (CNN Worldwide)
Food Insecurity: The Hidden Crisis — Impact x Nightline (ABC News Studios | Hulu)
Homelessness in America: The Forgotten Population — Fault Lines (Al Jazeera International USA)
WINNER: The Fight Against Child Trafficking — Trafficked with Mariana van Zeller (Muck Media [National Geographic])
Uncovering Police Brutality in Small Town America — View From Above (Business Insider)
Outstanding Science, Technology or Environmental Journalism
Climate Change: The Reality Check — The Whole Story with Anderson Cooper (CNN Worldwide)
Inside Big Tech: The Truth About Your Data — The New Economy (CNN Business)
Life Beyond Earth: The Search for Extraterrestrial Life — View From Above (Business Insider)
WINNER: The Future of Food: Sustainable Solutions for a Hungry Planet — Trafficked with Mariana van Zeller (Muck Media [National Geographic])
The Science of Addiction: Breaking the Cycle — Impact x Nightline (ABC News Studios | Hulu)
As the world continues to navigate the challenges of the ongoing COVID-19 pandemic, scientists and researchers are working tirelessly to develop effective treatments and vaccines to combat the virus. One promising avenue of research involves the use of monoclonal antibodies, which have shown significant potential in the fight against COVID-19.
Monoclonal antibodies are laboratory-made proteins that mimic the immune system’s ability to fight off harmful pathogens such as viruses. These antibodies are designed to target specific proteins on the surface of the virus, preventing it from entering and infecting human cells. By neutralizing the virus in this way, monoclonal antibodies can help to reduce the severity of COVID-19 symptoms and improve patient outcomes.
Several monoclonal antibody treatments have already been granted emergency use authorization by regulatory agencies such as the US Food and Drug Administration (FDA). These treatments have shown promising results in clinical trials, with some studies suggesting that they can reduce the risk of hospitalization and death in patients with COVID-19.
One of the key advantages of monoclonal antibody therapies is their ability to provide immediate immunity to individuals who have been exposed to the virus. This can be particularly beneficial for those who are at high risk of developing severe complications from COVID-19, such as the elderly or individuals with underlying health conditions.
However, there are also challenges associated with the widespread use of monoclonal antibodies as a treatment for COVID-19. One of the main concerns is the cost and availability of these therapies, which can be prohibitively expensive for many patients. Additionally, there are logistical challenges involved in administering these treatments, as they must be given intravenously in a healthcare setting.
Despite these challenges, researchers are optimistic about the potential of monoclonal antibodies to help control the spread of COVID-19 and reduce its impact on global health. Ongoing research is focused on developing new and improved monoclonal antibody therapies, as well as exploring novel approaches to delivering these treatments more effectively and efficiently.
In conclusion, monoclonal antibodies represent a promising avenue of research in the fight against COVID-19. These therapies have shown significant potential in reducing the severity of symptoms and improving outcomes for patients with the virus. While there are challenges to overcome, the development and use of monoclonal antibodies offer hope for a brighter future in the battle against COVID-19. The COVID-19 pandemic has brought about unprecedented challenges and changes to the world as we know it. From lockdowns and social distancing measures to economic downturns and remote work, the impact of the virus has been felt far and wide. As countries around the globe continue to battle the spread of the virus and work towards finding a solution, one thing has become increasingly clear – the need for innovation and adaptability in the face of adversity.
One area where innovation has been particularly crucial during this time is in the field of healthcare. With hospitals overwhelmed and medical resources stretched thin, healthcare providers have had to find new ways to deliver care and treat patients. Telemedicine, for example, has seen a surge in popularity as doctors and patients alike turn to virtual appointments to minimize the risk of exposure to the virus.
Another area where innovation has played a key role during the pandemic is in the development of vaccines. The unprecedented speed at which COVID-19 vaccines were developed and brought to market is a testament to the power of innovation and collaboration in the face of a global crisis. Scientists and researchers around the world worked tirelessly to develop safe and effective vaccines in record time, paving the way for a return to normalcy.
In addition to healthcare, innovation has also been crucial in other industries during the pandemic. Businesses have had to adapt to new ways of working, with many transitioning to remote work and implementing new technologies to stay connected with employees and customers. The rise of e-commerce and contactless delivery services has allowed businesses to continue operating and serving customers while minimizing the risk of exposure to the virus.
Education is another area where innovation has been essential during the pandemic. With schools and universities closed for in-person learning, educators have had to find new ways to deliver lessons and engage students remotely. Online learning platforms and virtual classrooms have become the new norm, allowing students to continue their education from the safety of their homes.
As we continue to navigate the challenges of the COVID-19 pandemic, one thing is clear – innovation will be key to overcoming this crisis and building a better future. By embracing new technologies, adapting to changing circumstances, and working together towards a common goal, we can emerge from this crisis stronger and more resilient than ever before. The power of innovation in the face of adversity is undeniable, and it will be crucial in shaping the world that emerges on the other side of this pandemic.
